Although Bcl-2, an anti-apoptotic protein known to be upregulated in uveal melanoma, was decreased in 5 of 7 samples, no clear pattern was seen with markers of proliferation or metabolic activity to further explain the lack of tumor response with treatment. Here, BCL2 is linked to uveal melanoma.